The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Share News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Trades Flat Prior To US Open; Nyota, Plethora Lead AIM

Fri, 20th Sep 2013 13:06

LONDON (Alliance News) - London's main equity indices are flat ahead of the US market open, as the markets continue to stabilise following large gains made Thursday in the aftermath of the US Federal Reserve's decision not to taper its monthly USD85 billion stimulus programme.

Commentators at Accendo Markets and Spreadex suggest that Friday may have seen investors shift away from viewing the Fed's decision as positive outcome, since it keeps cheap money flowing, towards seeing the decision as potentially negative, since it could be seen as proof that the US economy still needs a lot of support.

Prior to the US market open, the FTSE 100 is down 0.2% at 6,612.85, the FTSE 250 is down 0.1% at 15,118.69, and the AIM All-Share is up 0.4% at 793.14.

At an individual stock level, the continuing fall in the price of gold, down 1.2% at USD1349.70 per ounce, means that mining companies are some of the big fallers on both the FTSE 100 and the FTSE 250. Fresnillo is down 3.3%, Randgold Resources is down 3.1%, Anglo American is down 2.7%, and Hochschild Ming is down 3.1%.

Nyota Minerals continues to be a big winner on the AIM index after its biggest shareholder, Centamin PLC, said it had launched an attempt to oust Nyota's chief executive because it was unhappy with the way Nyota is being managed and wants to move strategy on.

Plethora Solutions share price has jumped 100% on the news that the company's premature ejaculation spray has moved a step closer to receiving approval after the European Medicines Agency's Committee for Medicinal Products for Human Use recommended its approval by the European Commission.

Following on from the London markets, US futures are pointing to a flat open across the major markets with the S&P pointing down 0.2%, the DJIA down 0.1% and the Nasdaq expected to open flat.

In the data calendar, EU consumer confidence is scheduled for 1500 BST, whilst post-embargo speeches from individual FOMC members begin with Esther George and James Bullard after the European market close.

By James Kemp; jameskemp@alliancenews.com

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
23 Dec 2015 09:39

Plethora Agrees GBP1.0 Million Loan Facility With Buyer Regent Pacific

Read more
22 Dec 2015 12:02

Port Erin Biopharma Continues To Look For Investments, Swings To Loss

Read more
15 Dec 2015 13:57

Plethora Solutions recommends GBP96m Regent Pacific offer

(ShareCast News) - Plethora Solutions, which is developing a treatment for premature ejaculation, has agreed on a takeover by Hong Kong-listed Regent Pacific that values the AIM company at roughly £96m or 11.65p per share. At Regent Pacific's closing price on Monday, this valued Plethora at a level

Read more
15 Dec 2015 13:47

Regent Pacific To Acquire Plethora Solutions For GBP114.3 Million

Read more
4 Nov 2015 12:19

LONDON MARKET MIDDAY: US Stocks Seen Up Ahead Of Data, Earnings

Read more
4 Nov 2015 10:32

Plethora Solutions Shares Soar, Agrees Regent Pacific Takeover Terms

Read more
4 Nov 2015 10:31

WINNERS & LOSERS SUMMARY: Housebuilders And Estate Agents Torn Down

Read more
28 Aug 2015 15:36

Plethora Interim Loss Narrows As Product Development Continues

Read more
5 Jun 2015 11:30

Plethora Ends Deal With Sharwood, Substitutes Deal With Regent Pacific

Read more
12 May 2015 08:43

Plethora Solutions Appoints New CFO, Non-Executive Director

Read more
30 Mar 2015 12:15

Port Erin Biopharma Swings To First Half Loss As Gains Do Not Recur

Read more
11 Nov 2014 10:48

Plethora Says Fortacin Prescription Sales May Hit USD1 Billion A Year

Read more
10 Nov 2014 09:50

Plethora Solutions Continues Progress Towards Launch Of Fortacin

Read more
7 Oct 2014 08:50

Plethora Solutions' Treatment To Be Marketed As Fortacin In EU

Read more
29 Sep 2014 13:40

Plethora Says Forest Nominees To Convert Loan Notes Into Shares (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.